HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

The National Institute for Health and Care Excellence (NICE) has [...]

CellProthera has acquired full rights to the transendocardial catheter originally [...]

NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]

CellProthera has published peer-reviewed results from its phase 1/2b Excellent [...]

Daxor Corporation, a global leader in blood volume measurement technology, [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]

First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]